NanoDetection Technology issues report on product pipeline

NanoDetection Technology, Inc., a Franklin, Ohio-based company that develops diagnostic tests for potential lethal pathogens, released a report on Tuesday analyzing the company's 2013 product pipeline.

The report, which is available through Fast Market Research, serves as a source of data, analysis and actionable intelligence on NanoDetection Technology's portfolio of pipeline products. The report provides analysis on products in the pipeline, with information on the indication, product milestones, development stage, trial phase, pipeline territory, estimated approval date and estimated launch date of each product.

The report also includes a detailed company profile and any applicable information on clinical trials.

According to the company's website, the NDT detector combines 25 discreet photodiodes into an integrated computer biochip with application specific integrated circuit design. The detector is able to detect multiple pathogens at a time and can transfer data using a digital signal. The NDT detector is also able to obtain field tracking and positioning through GPS.

NanoDetection Technology sells pathogen detection systems to the bioterrorism, human healthcare and food safety markets. The company develops multiple pathogen assays for multiple fields, including ricin and anthrax for the bioterrorism market, Methicillin-resistant Staphylococcus aureus and urinary tract infection bacteria for the healthcare setting and Salmonella, Listeria and E. coli for the food chain field.